福泰制药

438.95
开盘价
444.54
市值
113.62B+
最高价
449.62
最低价
438.35
收盘价
NaN
成交量
424.47K+
市盈率
29.19
股息率
0.00%

福泰制药简介

Vertex Pharmaceuticals,Inc.从事发现,开发,生产和商业化针对严重疾病患者的小分子药物的业务。 它致力于开发和商业化用于治疗囊性纤维化,传染性疾病(包括病毒感染,例如流感和细菌感染),自身免疫性疾病(例如类风湿性关节炎,癌症,炎性肠病)和神经系统疾病(包括疼痛和多发性硬化症)的疗法,并将其商业化。 该公司由Joshua S. Boger于1989年创立,总部位于马萨诸塞州波士顿。

如何购买 福泰制药 (VRTX)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 VRTX

购买 VRTX

通过 RockFlow App 或网页端搜索 VRTX,输入您想要投资的金额,然后点击确认即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.